[1]
Ramachandran K, Rajesh Yadav, and Sumitra Devkota, “Risk for death increasing with cardiovascular chronic gout patients associated with febuxostat ”, ijrls, vol. 10, no. 1, pp. 14-17, Jun. 2020.